We fund only the highest quality research using a rigorous peer review process to determine the most relevant, important and worthy research.
We are members of the Association of Medical Research Council (AMRC) and adhere to their processes and guidance to ensure our funding and management of our research priorities are transparent and rigorous.
Annually, we make several calls which are advertised via the website and through networks of academic institutions, our NHS partners and clinical research collaborators.
Our calls are streamed reflecting our research strategy priorities. These streams are developed with individual criteria and researchers should read and adhere to the relevant application guidance and criteria advertised with the individual stream.
IMPORTANT RESEARCH UPDATE
In light of the current Covid-19 pandemic the Trustees of North West Cancer Research have paused a number of funding rounds in order to give us time to understand the impact of this unprecedented event on our finances and ability to generate funds going forwards. New funding rounds will be announced after September 2020 when we hope to resume funding.
For applicants to current rounds the following updates are available:
- Cancer Discovery – Closed April 2020 – This round is going ahead as expected and the Cancer Discovery panel will meet in July with final funding decisions being made by the Trustees at the end of the month.
- NWCR & Tenovus PhD Studentship – The closing date for this is Monday 22 June and we expect the process to run to its original timetable. The funding panel for this round will meet in September 2020 with the final decision being confirmed at the end of September following the NWCR Board of Trustees meeting. It is anticipated that the studentship will commence in September 2021.
Once funding rounds re-start after September it is likely that the first new opportunity will be for applied health services based research.